Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein

22Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A cytokine storm induces acute respiratory distress syndrome, the main cause of death in coronavirus disease 2019 (COVID-19) patients. However, the detailed mechanisms of cytokine induction due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain unclear. To examine the cytokine production in COVID-19, we mimicked the disease in SARS-CoV-2-infected alveoli by adding the lysate of SARS-CoV-2-infected cells to cultured macrophages or induced pluripotent stem cell-derived myeloid cells. The cells secreted interleukin (IL)-6 after the addition of SARS-CoV-2-infected cell lysate. Screening of 25 SARS-CoV-2 protein-expressing plasmids revealed that the N protein-coding plasmid alone induced IL-6 production. The addition of anti-N antibody further enhanced IL-6 production, but the F(ab’)2 fragment did not. Sera from COVID-19 patients also enhanced IL-6 production, and sera from patients with severer disease induced higher levels of IL-6. These results suggest that anti-N antibody promotes IL-6 production in SARS-CoV-2-infected alveoli, leading to the cytokine storm of COVID-19.

Cite

CITATION STYLE

APA

Nakayama, E. E., Kubota-Koketsu, R., Sasaki, T., Suzuki, K., Uno, K., Shimizu, J., … Shioda, T. (2022). Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-12252-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free